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1. Introduction
Development of a methodology to control the function of
peptides/proteins is an indispensable task in the field of chemical 
biology and drug delivery. Photo-responsive processing (peptide 
bond cleavage)1a-i or conformational change1j has been 
successfully applied for controlling peptide/protein function. 
Previously, we reported a stimulus responsive amino acid2 
including a photo-responsive one2a,c,d and its application for 
controlling peptidyl function in living cells2d (Scheme 1). Peptide 
1, possessing the stimulus-responsive amino acid, was converted 
to processing products 2 and 3 by stimulus-induced removal of 
PG (protective group removable by a stimulus) followed by 
lactonization of the trimethyl lock moiety.3 In previous reports, 
the racemic material was used as a stimulus-responsive amino 
acid;2 therefore, its incorporation into a peptide afforded a 
diastereomeric mixture of the peptide. Consequently, it has been 
desirable to synthesize a chiral stimulus-responsive amino acid 
for ease of purifying synthetic peptides. In this paper, we report 
enantioselective synthesis of a key intermediate of the stimulus- 
responsive amino acid and its application for preparing the Fmoc 
protected UV-responsive amino acid with (S)-configuration 
identical to that of naturally occurring amino acids. Incorporation 
of the UV-responsive amino acid into a model peptide is also 
reported. 
Scheme 1. Stimulus-responsive processing system (PG: protective group 
removable by a stimulus). 
2. Results and discussion
2.1. Enantioselective α-amination of aldehyde 4
An enantioselective α-amination of an aldehyde with a dialkyl 
azodicarboxylate in the presence of proline4,5 or its derivatives4,6  
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entry catalyst (eq.) solvent time yield of 5 (%) ee of 5 (%) 
1 6 (0.5) DMSO 7 d -a 20 
2 6 (0.1)b CH2Cl2 7 d -a 2c 
3 6 (0.1)b acetonitrile 7 d -a 10c 
4 7 (0.2)b CH2Cl2 7 d -a - 
5 7 (0.2)b acetonitrile 7 d -a - 
6 8 (0.1) toluene 3 d 22 >99c 
7 9 (0.1) CH2Cl2 3 d 67 >99 
8 9 (0.1) CH2Cl2 7 d 42 98 
9 9 (0.1) acetonitrile 1.5 d 42 78 
10 9 (0.1) acetonitrile d 4 d -a 18 
11 9 (0.5) CH2Cl2 3 d 85 >99 
12 9 (0.5) CH2Cl2d 3 d 37 84 
13 9 (0.5) acetonitrile 1.5 d 54 78 
14 9 (0.5) DMF 1 d 56 63 
15 9 (0.5) THF 3 d 70 79 
 
Table 1. Asymmetric α-amination of aldehyde 4. Reagents and conditions. (i) di-tert-butyl azodicarboxylate, catalyst, solvent, rt. (ii) NaBH4, 
MeOH. aAlmost all starting material was recovered. bAn enantiomer of the catalyst was used. cAn enantiomer of alcohol 5 was obtained as a 
major product. dWater (10% (v/v)) was added. 
 
is one of the most attractive methods for preparing chiral amino 
acid derivatives. Therefore, we applied these systems for 
enantioselective α-amination of aldehyde 42d (Table 1). Aldehyde 
4 was treated with di-tert-butyl azodicarboxylate in the presence 
of proline or its derivatives, and the resulting mixture was 
immediately reduced to alcohol 5 with sodium borohydride to 
prevent a racemization reaction. An enantiomeric excess was 
determined by chiral HPLC analysis of alcohol 5. Determination 
of the absolute configuration of alcohol 5 will be mentioned later. 
When proline 6 or sulfonamide 76n,7 was used as a catalyst, 
almost all starting material was recovered after a week of 
reaction (entries 1-5). In the presence of 0.1 equivalents of silyl 
ether 8,6j,7 an enantiomer of 5 was obtained enantioselectively 
(>99% ee); however, the chemical yield after 72 h of reaction 
was not sufficient (entry 6). A moderate chemical yield and high 
enantioselectivity were achieved using 0.1 equivalents of 
tetrazole 96m,7 in CH2Cl2 (entry 7). Prolonged reaction time 
decreased the chemical yield and enantioselectivity presumably 
due to side reactions of the generated aldehyde (entries 7 and 8). 
After optimization of reaction conditions (entries 7-15), alcohol 5 
with high enantiomeric purity was obtained in high yield using 
0.5 equivalents of tetrazole 9 in CH2Cl2 (entry 11, 85% yield, 
>99% ee).  
2.2. Determination of absolute configuration 
Next, we attempted to determine the absolute configuration of 
alcohol 5 using Kusumi’s method, also known as a modified 
Mosher’s method (Scheme 2).8 Aldehyde 4 was converted to 
alcohol 5 under the reaction conditions of entry 11 in Table 1. 
According to the previous report,2d crude alcohol 5 was 
derivatized to protected amino alcohol 11. Briefly, the hydroxyl 
group of 5 was protected with a tert-butyldimethylsilyl (TBS) 
group. Then, trifluoroacetylation of the terminal nitrogen of 10 
and subsequent reductive cleavage of the activated N–N bond 
afforded protected amino alcohol 11. Deprotection of the Boc 
group and the TBS group of 11 under acidic conditions followed 
by acylation with (R) or (S)-1-methoxy-1-phenyl-1-
trifluoromethylacetic acid afforded (R) or (S)-MTPA amide 12, 
respectively. For calculation of Δδ values, which was obtained by 
subtracting the chemical shift of (R)-MTPA derivative from that 
of (S)-MTPA derivative (Δδ = δ(S)-MTPA – δ(R)-MTPA), Ha, Hb, Hc and 
Hd were assigned on the basis of NOE experiment (Figure 1a). 
Then, the Δδ values were calculated and the absolute 
configuration of amide 12 was ascertained as (S) (Figure 1b).8b It 
is widely accepted that tetrazole 9-mediated α-amination of an 
aldehyde proceeds via hydrogen bonding of a tetrazole moiety of 
an enamine intermediate to a dialkyl azodicarboxylate to generate 
an aminated product with (S)-configuration (Figure 2).4a,6m 
Therefore, the enantioselectivity observed in our experiments 
agrees well with that of the previous report. 
 
 
Scheme 2. Reagents and conditions: (i) di-tert-butyl azodicarboxylate, 9 (0.5 
eq.), CH2Cl2. (ii) NaBH4, MeOH. (iii) TBSOTf, Et3N, CH2Cl2, 0 °C, 75% (3 
steps). (iv) trifluoroacetic anhydride, Et3N, CH2Cl2. (v) SmI2, tert-BuOH, 
HMPA, THF, 64% (2 steps). (vi) HCl, 1,4-dioxane. (vii) (S) or (R)-1-
methoxy-1-phenyl-1-trifluoromethylacetic acid, EDC·HCl, Et3N, CH2Cl2, 
36% (2 steps) for (R)-MTPA derivative, 38% (2 steps) for (S)-MTPA 
derivative. 
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Figure 1. Determination of the absolute configuration using Kusumi’s 
method. (a) Observed NOEs (arrows) with MTPA amide 12. (b) Δδ values 
(δ(S)-MTPA – δ(R)-MTPA) obtained for (S)- and (R)-MTPA amide 12 in CDCl3 with 
5% (v/v) D2O. 
 
 
Figure 2. Proposed transition state for the α-amination of aldehyde 4. 
 
2.3. Synthesis of chiral stimulus-responsive amino acid derivative 
Having chiral intermediate 11 with (S)-configuration, we then 
attempted to synthesize a chiral UV-responsive amino acid 
possessing an o-nitrobenzyl group as a phenolic protective group 
(Scheme 3).2d The benzyl group of 11 was removed by 
hydrogenolysis to afford phenol 13. In this reaction, accidental 
removal of the TBS group was sometimes observed;9 however, it 
was suppressed by the addition of sodium bicarbonate. Phenol 13 
is a key synthetic intermediate of stimulus-responsive amino 
acids.2a,b,d Therefore, an enantiomeric excess of 13 was 
ascertained by chiral HPLC and was determined as >99% ee. To 
demonstrate the applicability of chiral synthetic intermediate 13 
for synthesis of the stimulus-responsive amino acids, it was 
converted to UV-responsive amino acid derivative 16. Phenol 13 
was alkylated with o-nitrobenzyl bromide to afford ether 14 
(oNB: o-nitrobenzyl). Then, the silyl group of 14 was removed 
under acidic conditions to generate alcohol 15. Oxidation of 
alcohol 15 using pyridinium dichromate (PDC) in DMF was 
examined; however, a mixture of corresponding aldehyde and a 
small amount of the carboxylic acid was obtained. The use of 
PDC in DMF for oxidation of primary alcohols has been well 
documented to afford corresponding carboxylic acids.10 However 
in our case, the second step for the carboxylic acid did not 
proceed well, presumably due to the presence of a sterically 
hindered side chain functionality. Therefore, the obtained crude 
material was subjected to subsequent oxidation with NaClO2, 
followed by deprotection of the Boc group and protection of the 
generated amine with an Fmoc group to yield Fmoc amino acid 
16 in 84% yield over 4 steps. 
Unfortunately, attempts to determine the enantiomeric excess 
of 16 using chiral HPLC (ChiralPak IA, iPrOH/hexane system) 
were unsuccessful. In the previous report, we noted that peptide 
17 and its diastereomer 17′ derived from racemic 16 can be 
easily separated by reverse phase HPLC (Scheme 4).2d Therefore, 
we decided to estimate an enantiomeric excess of amino acid 
derivative 16 on the basis of a diastereomeric excess of the 
peptide. Peptide 17 was synthesized by Fmoc solid phase peptide 
synthesis according to the previous report. The obtained crude 
material was analyzed by reverse phase HPLC, and peptide 17 
was eluted at 21.0 min (Figure 3a). When racemic 16 was 
incorporated in the peptide, 17 and its diastereomer 17′ were 
eluted separately (retention time of 17′: 22.6 min) (Figure 3b). 
Based on these results, a diastereomeric excess of the peptide 
derived from 16 was calculated as >99% de. Therefore, an 
enantiomeric excess of Fmoc amino acid 16 was estimated as 
>99% ee. 
3. Conclusions and summary 
In conclusion, enantioselective synthesis of a key intermediate 
of stimulus-responsive amino acids via asymmetric α-amination 
reaction of the aldehyde was reported. An absolute configuration 
of the intermediate was ascertained as (S) using Kusumi’s 
method. The obtained chiral intermediate was applied for 
preparing the Fmoc protected UV-responsive amino acid with 
(S)-configuration and was successfully incorporated into a model 
peptide by Fmoc solid phase peptide synthesis. These results 
enable us to prepare chiral stimulus-responsive amino acids, not 
just the UV-responsive compound. Its application in synthesizing 
other stimulus-responsive amino acids is in progress. 
 
 
Scheme 3. Reagents and conditions: (i) H2, Pd/C, NaHCO3, MeOH, 83%, 
>99% ee. (ii) o-nitrobenzyl bromide, K2CO3, DMF, 84%. (iii) AcOH, H2O, 
THF, 93%. (iv) PDC, DMF. (v) NaClO2, 2-methyl-2-butene, NaH2PO4, 
acetonitrile, acetone, H2O. (vi) HCl, AcOEt. (vii) FmocOSu, Na2CO3, 
acetonitrile, H2O, 84% (4 steps). (oNB: o-nitrobenzyl) 
 
 
Scheme 4. Reagents and conditions: (i) Fmoc solid phase peptide synthesis 
on a NovaSyn TGR resin. (ii) TFA/triethylsilane/H2O = 95/2.5/2.5 (v/v/v). 
(oNB: o-nitrobenzyl; F: phenylalanine; G: glycine; L: leucine; Y: tyrosine) 
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Figure 3. HPLC profiles of a crude material of the peptide derived from 
(a) 16, or (b) racemic 16. Peptide 17′ is a diastereomer of peptide 17. 
Retention times, 17: 21.0 min; 17′: 22.6 min. Only a critical retention time 
region of the HPLC charts was enlarged. HPLC conditions: Cosmosil 5C18-
AR-II column (4.6 × 250 mm) with a linear gradient of 0.1% (v/v) TFA in 
acetonitrile/0.1% (v/v) aqueous TFA solution (20% to 80% over 30 min) at a 
flow rate of 1.0 mL/min, detection at 220 nm. 
 
4. Experimental section 
4.1. General methods 
All reactions were carried out under a positive pressure of 
argon unless otherwise noted. For column chromatography, silica 
gel (KANTO KAGAKU N-60) was employed. NMR spectra 
were measured using a JEOL GSX400, a Bruker AV400N, or a 
JEOL JNM-AL300 spectrometer. Exact mass spectra were 
recorded on a Waters MICROMASS® LCT PREMIERTM or a 
Bruker Esquire200T. Enantiomeric excesses were estimated by 
HPLC on a ChiralPak IA (Daicel Chiral Industries, Ltd., 4.6 × 
250 mm, detection at 220 nm). For reverse phase HPLC analysis, 
a Cosmosil 5C18-AR-II analytical column (Nacalai Tesque, 4.6 × 
250 mm) was employed and eluting products were detected by 
UV at 220 nm. Optical rotations were measured using a JASCO 
P-2200 polarimeter (concentration in g/100 mL). 
4.2. Typical procedure of α-amination reaction described in 
Table 1 (entry 11) 
To a solution of aldehyde 42d (50.0 mg, 169 μmol) in CH2Cl2 
(250 μL) were added di-tert-butyl azodicarboxylate (54.3 mg, 
236 μmol) and tetrazole 96m,7 (11.7 mg, 84.0 μmol), and the 
reaction mixture was stirred at room temperature for 72 h. After 
addition of saturated aqueous solution of NH4Cl, the resulting 
mixture was stirred for 30 min and then extracted with diethyl 
ether. The organic phase was washed with brine, dried over 
Na2SO4, and concentrated in vacuo. To the obtained crude 
material were successively added MeOH (2.00 mL) and sodium 
borohydride (8.0 mg, 210 μmol) at 0 °C. The resulting 
suspension was stirred at room temperature for 30 min. After 
addition of saturated aqueous solution of NH4Cl, the reaction 
mixture was stirred for 30 min and then extracted with AcOEt. 
The combined organic layer was washed with 5% (w/v) aqueous 
solution of KHSO4 followed by brine, dried over Na2SO4 and 
concentrated in vacuo. The crude product was purified by 
preparative TLC (SiO2, hexane/AcOEt = 2/1 (v/v)), and 75.7 mg 
of alcohol 5 (143 μmol, 85%, >99% ee) was obtained as a white 
powder. 1H NMR spectrum was identical with that of the racemic 
one.2d HPLC conditions: ChiralPak IA (hexane/iPrOH = 95/5 
(v/v), 0.25 mL/min). Retention times: 36.3 min (minor) and 57.6 
min (major). 
4.3. Asymmetric synthesis of Fmoc protected UV-responsive 
amino acid derivative 
4 .3 .1 .  (S) -3 -(2 -Benzyloxy-4 ,6-d imethylphenyl ) -2-
(1 ,2-d i- ter t -bu toxycarbonylhydraz inyl ) -3 ,3-
d imethylpropanol  (5 )  
Aldehyde 42d (1.33 g, 4.47 mmol) was converted to 
corresponding alcohol 5 according to the experiment 4.2. The 
crude product was reprecipitated from hexane, and 2.34 g of 
alcohol 5 was obtained as a white powder. It was used for a 
subsequent reaction without further purification. [α]19D +5.47 (c 
1.45, CHCl3); 1H NMR spectrum was identical with that of the 
racemic one.2d  
4.3 .2 .  (S) -3 -(2 -Benzyloxy-4 ,6-d imethylphenyl ) -2-
(1 ,2-d i- ter t -bu toxycarbonylhydraz inyl ) -3 ,3-
d imethylpropanol  ter t-bu tyld imethy ls i l y l  e ther  (10 )  
Alcohol 5 (2.34 g) was converted to corresponding silyl ether 
10 (2.16 g, 3.36 mmol, 75% over 3 steps) according to the 
previous report.2d [α]19D +17.1 (c 1.03, CHCl3); 1H NMR 
spectrum was identical with that of the racemic one. 
4.3 .3 .  (S) -3 -(2 -Benzyloxy-4 ,6-d imethylphenyl ) -2-
ter t -butoxycarbonylamino-3 ,3-d imethy lpropanol  
ter t -butyld imethyls i l y l  e ther  (11 )  
Hydrazine derivative 10 (2.16 g, 3.36 mmol) was converted to 
corresponding amine 11 (1.14 g, 2.16 mmol, 64% over 2 steps) 
according to the previous report.2d [α]21D -29.3 (c 1.06, CHCl3); 
1H NMR spectrum was identical with that of the racemic one. 
4.3 .4 .  (S) -2 -ter t -Bu toxycarbony lamino-3 ,3-
dimethyl -3 -(4 ,6 -d imethyl -2-hydroxypheny l)propanol  
ter t -butyld imethyls i l y l  e ther  (13 )  
Benzyl ether 11 (1.14 g, 2.16 mmol) was converted to 
corresponding phenol 13 (0.782 g, 1.79 mmol, 83%) according to 
the previous report.2d When desilylation had been observed, 
sodium bicarbonate (50 mg/MeOH 1.0 mL) was added to the 
reaction mixture. The enantiomeric excess was estimated as 
>99% ee. HPLC conditions: ChiralPak IA (hexane/iPrOH = 99/1 
(v/v), 0.25 mL/min). Retention times: 32.4 min (minor) and 37.4 
min (major). [α]20D -36.7 (c 0.95, CHCl3); 1H NMR spectrum was 
identical with that of the racemic one. 
4.3 .5 .  (S) -2 -ter t -Bu toxycarbony lamino-3 ,3-
dimethyl -3 -[2 ,4-d imethy l -6- (2 -
n i trobenzyloxy)pheny l] propanol  ter t -
butyld imethyls i l y l  e ther  (14 )  
5 
Phenol 13 (0.770 g, 1.76 mmol) was converted to 
corresponding nitrobenzyl ether 14 (0.840 g, 1.47 mmol, 84%) 
according to the previous report.2d [α]20D -35.5 (c 1.02, CHCl3); 
1H NMR spectrum was identical with that of the racemic one. 
4.3 .6 .  (S) -2 -ter t -Bu toxycarbony lamino-3 ,3-
dimethyl -3 -[2 ,4-d imethy l -6- (2 -
n i trobenzyloxy)pheny l] propanol  (15 )  
Silyl ether 14 (0.840 g, 1.47 mmol) was converted to 
corresponding alcohol 15 (0.623 g, 1.36 mmol, 93%) according 
to the previous report.2d [α]19D -18.9 (c 0.93, CHCl3); 1H NMR 
spectrum was identical with that of the racemic one. 
4.3 .7 .  (S) -3 ,3 -Dimethy l-3 -[2 ,4 -d imethyl -6 -(2 -
n i trobenzyloxy)pheny l] -2-(9 -
f luorenylmethoxycarbony lamino)propionic  acid  (16 )  
Pyridinium dichromate (1.93 g, 5.13 mmol) was added to a 
solution of alcohol 15 (470 mg, 1.02 mmol) in DMF (5.20 mL). 
The reaction mixture was stirred overnight. After addition of 5% 
(v/v) aqueous solution of KHSO4, the obtained mixture was 
extracted with diethyl ether. The combined organic layer was 
washed with brine, dried over Na2SO4, and concentrated in vacuo. 
The obtained crude material was subjected to subsequent 
reactions without purification according to the literature.2d Fmoc 
protected amino acid derivative 16 was obtained as a pale yellow 
amorphousness (514 mg, 84% over 4 steps). [α]23D -6.69 (c 1.12, 
CHCl3); 1H NMR spectrum was identical with that of the racemic 
one. 
4.4. Determination of  absolute configuration using Kusumi’s 
method 
4 .4 .1 .  General  procedure for  synthes is  o f  MTPA 
deriva t ives  
Hydrogen chloride in 1,4-dioxane (4 M, 1.0 mL) was added to 
substrate 11 (51 mg, 95 μmol) and the resulting mixture was 
stirred for 6 h. After being quenched with 1 M aqueous NaOH, 
the reaction mixture was extracted with CH2Cl2. The organic 
phase was dried over Na2SO4 and concentrated in vacuo to give a 
crude product. To the crude product in CH2Cl2 (1.0 mL) were 
added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC·HCl, 1.2 eq.), (R) or (S)-1-methoxy-1-
phenyl-1-trifluoromethylacetic acid (1.2 eq.) and triethylamine 
(1.0 eq.), and the reaction mixture was stirred overnight. After 
being quenched with saturated aqueous solution of NH4Cl, the 
reaction mixture was extracted with AcOEt. The organic phase 
was washed with brine, dried over Na2SO4, and concentrated in 
vacuo. The obtained product was purified by column 
chromatography (hexane/AcOEt = 6/1 (v/v)), and MTPA amide 
(R)-12 or (S)-12 was obtained respectively as a yellow oil.  
4.4 .2 .  (R) -MTPA deriva t ive  ((R)-12 )  
[α]28D -9.89 (c 2.17, CHCl3); 1H NMR (CDCl3 with 5% (v/v) 
D2O, 400 MHz) δ = 1.495 (3H, s), 1.566 (3H, s), 2.228 (3Hc, s), 
2.507 (3Ha, s), 3.17 (3H, s), 3.533 (1H, dd, J = 11.6 and 8.0 Hz), 
3.687 (1H, dd, J = 11.6 and 2.8 Hz), 4.912 (1H, td, J = 8.0 and 
2.8 Hz), 5.060 (1H, d, J = 11.8 Hz), 5.133 (1H, d, J = 12.0 Hz), 
6.594 (1Hb, s), 6.673 (1Hd, s), 7.25-7.45 (8H, m), 7.54 (2H, m); 
13C NMR (CDCl3, 75 MHz) δ = 20.7 (CH3), 25.9 (CH3), 27.9 
(CH3), 29.0 (CH3), 43.3 (C), 54.8 (CH3), 58.9 (CH), 64.7 (CH2), 
71.1 (CH2), 112.9 (CH), 127.6 (CH), 127.7 (CH), 127.9 (CH), 
127.9 (CH), 128.5 (CH), 128.6 (CH), 129.4 (CH), 129.5 (C), 
132.8 (C), 136.8 (C), 137.0 (C), 138.1 (C), 158.4 (C), 168.0 (C); 
HRMS (ESI-TOF) calc. for C30H34F3NNaO4 ([M+Na]+): 
552.2338, found: 552.2357. 
4.4 .3 .  (S) -MTPA derivat ive  ( (S) -12 )  
[α]28D +11.3 (c 1.19, CHCl3); 1H NMR (CDCl3 with 5% (v/v) 
D2O, 400 MHz) δ = 1.492 (3H, s), 1.540 (3H, s), 2.243 (3Hc, s), 
2.484 (3Ha, s), 3.27 (3H, s), 3.589 (1H, dd, J = 11.2 and 8.0 Hz), 
3.791 (1H, dd, J = 11.2 and 2.4 Hz), 4.927 (1H, td, J = 8.0 and 
2.4 Hz), 4.955 (1H, d, J = 12.4 Hz), 4.985 (1H, d, J = 12.4 Hz), 
6.571 (1Hb, s), 6.579 (1Hd, s), 7.09 (2H, d, J = 7.8 Hz), 7.21 (2H, 
t, J = 7.8 Hz), 7.28-7.46 (6H, m); 13C NMR (CDCl3, 75 Hz) δ = 
20.8 (CH3), 25.8 (CH3), 28.4 (CH3), 28.7 (CH3), 43.3 (C), 54.8 
(CH3), 58.8 (CH), 64.4 (CH), 71.2 (CH2), 100.5 (C), 112.9 (CH), 
127.5 (CH), 127.8 (CH), 128.0 (CH), 128.3 (CH), 128.6 (CH), 
129.2 (CH), 129.8 (C), 1323 (C), 136.8 (C), 136.8 (C), 137.8 (C), 
158.4 (C), 167.9 (C); HRMS (ESI-TOF) calc. for 
C30H34F3NNaO4 ([M+Na]+): 552.2338, found: 552.2321. 
4.5. Synthesis of peptide 17 
Peptide 17 was synthesized on NovaSyn TGR resin using 
Fmoc solid phase peptide synthesis reported in the previous 
report.2d The resulting crude material was analyzed by reverse 
phase HPLC. HPLC conditions: Cosmosil 5C18-AR-II analytical 
column (0.1% (v/v) TFA in acetonitrile/0.1% (v/v) aqueous TFA 
solution = 20 to 80% over 30 min, 1.0 mL/min). Retention times, 
17: 21.0 min; 17′: 22.6 min. MS (ESI-IT) calc. for C76H96N13O16 
([M+H]+): 1446.7, 17: found 1446.5, 17′: found 1446.4. 
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